Bead-Based Multiplex Genotyping of Human Papillomaviruses
暂无分享,去创建一个
Peter J. F. Snijders | P. Snijders | M. Pawlita | M. Schmitt | T. Waterboer | L. Gissmann | I. Bravo | Michael Pawlita | Tim Waterboer | Lutz Gissmann | Markus Schmitt | I. G. Bravo
[1] David R. Scott,et al. Improved Amplification of Genital Human Papillomaviruses , 2000, Journal of Clinical Microbiology.
[2] M. Weiner,et al. Fluorescent microsphere‐based readout technology for multiplexed human single nucleotide polymorphism analysis and bacterial identification , 2001, Human mutation.
[3] H. Hausen. Papillomaviruses and cancer: from basic studies to clinical application , 2002, Nature Reviews Cancer.
[4] B. Woda,et al. Facile, comprehensive, high-throughput genotyping of human genital papillomaviruses using spectrally addressable liquid bead microarrays. , 2005, The Journal of molecular diagnostics : JMD.
[5] P. Berger,et al. Christianity and Democracy: The Global Picture , 2004 .
[6] V. Moreno,et al. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study , 2002, The Lancet.
[7] D. Higgins,et al. T-Coffee: A novel method for fast and accurate multiple sequence alignment. , 2000, Journal of molecular biology.
[8] P. Hillemanns,et al. Primary cervical cancer screening by self-sampling of human papillomavirus DNA in internal medicine outpatient clinics. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[9] F. Bray,et al. Cancer burden in the year 2000. The global picture. , 2001, European journal of cancer.
[10] C. Peyton,et al. Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Products by a Single-Hybridization, Reverse Line Blot Detection Method , 1998, Journal of Clinical Microbiology.
[11] P. Snijders,et al. POBASCAM, a population‐based randomized controlled trial for implementation of high‐risk HPV testing in cervical screening: Design, methods and baseline data of 44,102 women , 2004, International journal of cancer.
[12] S. Dunbar,et al. Microsphere suspension array technology for SNP detection in cattle , 2003, IEEE Engineering in Medicine and Biology Magazine.
[13] F. X. Bosch,et al. Chapter 1: Human papillomavirus and cervical cancer--burden and assessment of causality. , 2003, Journal of the National Cancer Institute. Monographs.
[14] J. Peto,et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.
[15] P. Snijders,et al. GP5+/6+ PCR followed by Reverse Line Blot Analysis Enables Rapid and High-Throughput Identification of Human Papillomavirus Genotypes , 2002, Journal of Clinical Microbiology.
[16] Wim Quint,et al. Development and Clinical Evaluation of a Highly Sensitive PCR-Reverse Hybridization Line Probe Assay for Detection and Identification of Anogenital Human Papillomavirus , 1999, Journal of Clinical Microbiology.
[17] F. X. Bosch,et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.
[18] K. Zanotti,et al. New cervical cancer screening strategy: combined Pap and HPV testing. , 2005, Cleveland Clinic journal of medicine.
[19] J. Berkhof,et al. Prevalence of types 16 and 33 is increased in high‐risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse , 2005, International journal of cancer.
[20] S. Dunbar,et al. Quantitative, multiplexed detection of bacterial pathogens: DNA and protein applications of the Luminex LabMAP system. , 2003, Journal of microbiological methods.
[21] C. Meijer,et al. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. , 1995, The Journal of general virology.
[22] Markus F Templin,et al. Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. , 2005, Clinical chemistry.
[23] A. Mazumder,et al. Suspension arrays for high throughput, multiplexed single nucleotide polymorphism genotyping. , 2000, Cytometry.
[24] C. Meijer,et al. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings , 1997, Journal of clinical microbiology.
[25] M. Hakama,et al. Comparison of HPV test versus conventional and automation‐assisted Pap screening as potential screening tools for preventing cervical cancer , 2004, BJOG : an international journal of obstetrics and gynaecology.
[26] C J L M Meijer,et al. The causal relation between human papillomavirus and cervical cancer. , 2002, Journal of clinical pathology.